MESA LABORATORIES INC /CO/ Earnings Per Share Disclosure
Note 10. Net (Loss) Earnings Per Share
(dollars and shares in thousands, except per share values)
The following table presents a reconciliation of the denominators used in the computation of basic and diluted net (loss) earnings per share:
| Year Ended March 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Net (loss) earnings available for shareholders | $ | (1,974 | ) | $ | (254,246 | ) | $ | 930 | ||||
| Weighted average outstanding shares of common stock | 5,421 | 5,386 | 5,321 | |||||||||
| Dilutive effect of stock options | - | - | 26 | |||||||||
| Dilutive effect of unvested stock awards | - | - | 14 | |||||||||
| Fully diluted shares | 5,421 | 5,386 | 5,361 | |||||||||
| Basic (loss) earnings per share | $ | (0.36 | ) | $ | (47.20 | ) | $ | 0.17 | ||||
| Diluted (loss) earnings per share | $ | (0.36 | ) | $ | (47.20 | ) | $ | 0.17 | ||||
The following stock awards were excluded from the calculation of diluted EPS as their inclusion would be anti-dilutive:
| Year Ended March 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Assumed conversion of convertible debt | 351 | 608 | 608 | |||||||||
| Stock awards that were anti-dilutive | 386 | 268 | 154 | |||||||||
| Total stock awards excluded from diluted EPS | 737 | 876 | 762 | |||||||||
Shares underlying the Notes were excluded from the diluted EPS calculation for the years ended March 31, 2025, 2024 and 2023 as the impact of the assumed conversion of the Notes calculated under the if-converted method was anti-dilutive.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | May 28, 2025 | Showing above |
| 2024 | Jun 28, 2024 | |
| 2023 | May 30, 2023 | |
| 2022 | May 31, 2022 | |
| 2021 | Jun 1, 2021 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.